Abstract | PURPOSE: PATIENTS AND METHODS: Single-surgeon case series of 82 eyes of 82 patients undergoing DS with MMC. The patients had previous CE with IOL and/or conjunctival GS and treated intraocular pressure (IOP) >18 mm Hg. MMC (0.2 mg/ml) was applied for 2-3 min before scleral flap dissection. Complete success was defined as IOP between 6 and 21 mm Hg or a reduction of 20% from baseline without medications. Reoperation for glaucoma or related complications, or loss of light perception vision was considered as failure. RESULTS: Mean follow-up was 57.7 ± 22.4 months with 78% of patients completing the 3-year follow-up. Mean IOP decreased from 24.0 mm Hg (22.3-25.6, 95% confidence intervals) to 13.4 mm Hg (12.0-14.2) at 3 years after surgery (P<0.001). There was a significant decrease in the number of glaucoma medications from 2.0 ± 1 preoperatively, to 0.3 ± 0.7, 3 years after surgery. Kaplan-Meier cumulative success rates were 85.6% at 1 year, 80.0% at 2 years, and 76% at 3 years. At 3 years, IOP was maintained <19 and 15 mm Hg in 83 and 70% of eyes, respectively. Fourteen eyes (17.1%) had complications. Delayed hypotony (IOP <6 mm Hg) was the commonest complication in five eyes (6.1%). CONCLUSION: DS with MMC appears to be a safe and effective surgical procedure for eyes with previous intraocular surgery.
|
Authors | N Anand, D Wechsler |
Journal | Eye (London, England)
(Eye (Lond))
Vol. 26
Issue 1
Pg. 70-9
(Jan 2012)
ISSN: 1476-5454 [Electronic] England |
PMID | 21979860
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Analysis of Variance
- Female
- Glaucoma
(drug therapy, physiopathology, surgery)
- Humans
- Intraocular Pressure
(drug effects)
- Intraoperative Care
(methods)
- Male
- Minimally Invasive Surgical Procedures
- Mitomycin
(therapeutic use)
- Postoperative Complications
- Pseudophakia
(physiopathology, surgery)
- Reoperation
- Retrospective Studies
- Sclera
(drug effects, physiopathology, surgery)
- Sclerostomy
(methods)
- Trabeculectomy
- Visual Acuity
|